We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ligand (LGND) Breakout!
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
32384 155 0 LGND
Emcee:  Henry Niman Type:  Unmoderated

Today LGND made a major announcement at the Bear Stearns' Biotech
conference this morning. One of LGND's retinoids, Targretin, is in advanced
clinical trials for a wide range of cancers. Today LGND indicated
that pre-clinical data (in mice and rats) suggested additional
indications (for type II diabetes and breast cancer). Over 1/2
million shares traded in the first hour and the price has moved
to 15 1/4 (from yesterday's close of 13 1/8).

Henry N Fox Chapel
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
32384Ligand pipeline called a pipe dream by short seller. Would love to hear folks ttuck-1/16/2019
32383Ligand Pharmaceuticals Incorporated ( LGND) announces results from a Phase 1b clnigel bates16/8/2015
32382Ligand Pharmaceuticals Incorporated (LGND) announced the August 12, 2014 pricingnigel bates18/13/2014
32381Ligand Pharmaceuticals Incorporated (LGND) today announced that its partner Glaxnigel bates-7/23/2014
32380Ligand Pharmaceuticals Incorporated (LGND) announces that its partner GlaxoSmithnigel bates-6/25/2014
32379Ligand Pharmaceuticals Incorporated (LGND) announced the signing of an exclusivenigel bates-6/24/2014
32378Ligand Pharmaceuticals Incorporated ( LGND) announces that its partner, GlaxoSminigel bates-6/13/2014
32377Interesting.nigel bates-7/22/2013
32376Wonder if it could have something to do with this? medicalxpress.comrkrw-7/22/2013
32375SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) nigel bates-7/22/2013
32374SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) nigel bates-6/20/2013
32373Ligand to Receive $2 Million Milestone Payment from Merck Triggered by InitiatioSavant-10/23/2012
32372BOSTON (MarketWatch) -- Twelve biotech stocks traded on the NASDAQ market hit 5Savant-8/8/2012
32371Ligand Pharmaceuticals Announces Second Quarter Results Conference call beginsSavant-8/8/2012
32370Ligand Licensee Onyx Pharmaceuticals Receives FDA Accelerated Approval of KyproSavant-7/23/2012
32369Ligand Partner Pfizer Announces European Medicines Agency Accepts Regulatory SuSavant-7/19/2012
32368Ligand Announces New Presentation Time at the JMP Securities 7th Annual HealthcSavant-7/9/2012
32367Ligand Announces Positive Preclinical Data on LGD-6972 at the American Diabetes Savant-6/11/2012
32366well it looks like my pcop contingent rights just expired....mopgcw-1/18/2012
32365Lampert buys a slug here.mopgcw-10/6/2011
32364more insider buying,.mopgcw-8/31/2011
32363lampert buys in here...mopgcw-8/10/2011
32362San Diego’s Ligand Takes Advantage of the Great Recession to Build New Drug Pipemopgcw-3/25/2011
32361continued insider buying..mopgcw-3/9/2011
32360insider buy here...mopgcw-2/17/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):